Digital Cognitive Behavioral Therapy Feasible for Women With Migraine and Insomnia
March 13th 2020A proof‐of‐concept assessment showed that women with chronic migraine and insomnia can be reasonably treated with digital cognitive behavioral therapy for insomnia, with data suggesting it may improve both conditions.
Plasma Phosphorylated Tau181 Shows Diagnostic, Prognostic Promise for Alzheimer
March 12th 2020Study results suggest that the plasma P-tau181 biomarker may be an effective noninvasive biomarker for Alzheimer disease, with prognostic and diagnostic value for use in both clinical practice and clinical trials.